FDA Adverse Event Injury Summary report: N

BREATHTEK UBT

MDR report key: 13930298 · Received March 28, 2022

Report

Report Number
1524213-2022-00003
Event Type
Injury
Date Received
March 28, 2022
Date of Event
February 28, 2022
Report Date
March 28, 2022
Manufacturer
MERIDIAN BIOSCIENCE INC.
Product Code
OZA
UDI-DI
00840733101434
PMA / PMN Number
P100025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

PATIENT REPORTED COMPLICATIONS AFTER DRINKING PRANACTIN-CITRIC SOLUTION. PATIENT SAID SHE HAD "BUBBLE GUTS" FOR 20 MINUTES AFTER DRINKING SOLUTION AND THEN DID NOT PRODUCT STOOL FOR 4 DAYS AFTER. PATIENT REPORTED COMPLICATIONS AFTER DRINKING PRANACTIN-CITRIC SOLUTION. PATIENT SAID SHE HAD "BUBBLE GUTS" FOR 20 MINUTES AFTER DRINKING SOLUTION AND THEN DID NOT PRODUCT STOOL FOR 4 DAYS AFTER. THE PRODUCT LABELING INCLUDES A PRECAUTIONARY STATEMENT REGARDING THAT THOSE WHO ARE HYPERSENSITIVE TO MANNITOL SHOULD AVOID TAKING THE DRUG SOLUTION. HYPERSENSITIVITY IS A KNOWN REACTION THAT IS ALSO IDENTIFIED WITHIN THE LABELINGS POST-MARKETING EXPERIENCES SECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
321115 BREATHTEK UBT BREATHTEK UBT OZA MERIDIAN BIOSCIENCE INC. 01 453K05L 00840733101434

Patients

Seq Age Sex Outcome Treatment
1 42 YR Female